Anderson KC - Search Results

1

Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ multiple myeloma cells.

Tassone P, Goldmacher VS, Neri P, Gozzini A, Shammas MA, Whiteman KR, Hylander-Gans LL, Carrasco DR, Hideshima T, Shringarpure R, Shi J, Allam CK, Wijdenes J, Venuta S, Munshi NC, Anderson KC. Tassone P, et al. Among authors: anderson kc. Blood. 2004 Dec 1;104(12):3688-96. doi: 10.1182/blood-2004-03-0963. Epub 2004 Aug 3. Blood. 2004. PMID: 15292058 Free article.

2

Advances in the biology of multiple myeloma: therapeutic applications.

Anderson K. Anderson K. Semin Oncol. 1999 Oct;26(5 Suppl 13):10-22. Semin Oncol. 1999. PMID: 10528890 Review.

3

CD40 activation induces p53-dependent vascular endothelial growth factor secretion in human multiple myeloma cells.

Tai YT, Podar K, Gupta D, Lin B, Young G, Akiyama M, Anderson KC. Tai YT, et al. Among authors: anderson kc. Blood. 2002 Feb 15;99(4):1419-27. doi: 10.1182/blood.v99.4.1419. Blood. 2002. PMID: 11830495 Free article.

4

Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays.

Chauhan D, Auclair D, Robinson EK, Hideshima T, Li G, Podar K, Gupta D, Richardson P, Schlossman RL, Krett N, Chen LB, Munshi NC, Anderson KC. Chauhan D, et al. Among authors: anderson kc. Oncogene. 2002 Feb 21;21(9):1346-58. doi: 10.1038/sj.onc.1205205. Oncogene. 2002. PMID: 11857078

5

NF-kappa B as a therapeutic target in multiple myeloma.

Hideshima T, Chauhan D, Richardson P, Mitsiades C, Mitsiades N, Hayashi T, Munshi N, Dang L, Castro A, Palombella V, Adams J, Anderson KC. Hideshima T, et al. Among authors: anderson kc. J Biol Chem. 2002 May 10;277(19):16639-47. doi: 10.1074/jbc.M200360200. Epub 2002 Feb 28. J Biol Chem. 2002. PMID: 11872748 Free article.

6

Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells.

Mitsiades N, Mitsiades CS, Poulaki V, Anderson KC, Treon SP. Mitsiades N, et al. Among authors: anderson kc. Blood. 2002 Mar 15;99(6):2162-71. doi: 10.1182/blood.v99.6.2162. Blood. 2002. PMID: 11877293 Free article.

7

CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications.

Treon SP, Pilarski LM, Belch AR, Kelliher A, Preffer FI, Shima Y, Mitsiades CS, Mitsiades NS, Szczepek AJ, Ellman L, Harmon D, Grossbard ML, Anderson KC. Treon SP, et al. Among authors: anderson kc. J Immunother. 2002 Jan-Feb;25(1):72-81. doi: 10.1097/00002371-200201000-00008. J Immunother. 2002. PMID: 11924912 Clinical Trial.

8

S-3-Amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice.

Lentzsch S, Rogers MS, LeBlanc R, Birsner AE, Shah JH, Treston AM, Anderson KC, D'Amato RJ. Lentzsch S, et al. Among authors: anderson kc. Cancer Res. 2002 Apr 15;62(8):2300-5. Cancer Res. 2002. PMID: 11956087

9

Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications.

Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T, Munshi N, Treon SP, Anderson KC. Mitsiades N, et al. Among authors: anderson kc. Blood. 2002 Jun 1;99(11):4079-86. doi: 10.1182/blood.v99.11.4079. Blood. 2002. PMID: 12010810 Free article.

10

Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications.

Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T, Munshi NC, Treon SP, Anderson KC. Mitsiades N, et al. Among authors: anderson kc. Blood. 2002 Jun 15;99(12):4525-30. doi: 10.1182/blood.v99.12.4525. Blood. 2002. PMID: 12036884 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,226 results

Search Page

Filters